Cyclic‐di‐GMP induces inflammation and acute lung injury through direct binding to MD2
Clinical and Translational Medicine · 2024
DOI: 10.1002/ctm2.1744 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical and Translational Medicine, 2024. Verfasst von Chenchen Qian und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China. Hauptthemen laut MEDLINE: Acute Lung Injury, Lymphocyte Antigen 96, Cyclic GMP, COVID-19. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Research Project of Wenzhou City, National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Severe bacterial infections can trigger acute lung injury (ALI) and acute respiratory distress syndrome, with bacterial pathogen‐associated molecular patterns (PAMPs) exacerbating the inflammatory response, particularly in COVID‐19 patients. Cyclic‐di‐GMP (CDG), one of the PAMPs, is synthesized by various Gram‐positve and Gram‐negative bacteria. Previous studies mainly focused on the inflammatory responses triggered by intracellular bacteria‐released CDG. However, how extracellular CDG, which is released by bacterial autolysis or rupture, activates the inflammatory response remains unclear.
Methods
The interaction between extracellular CDG and myeloid differentiation protein 2 (MD2) was investigated using in vivo and in vitro models. MD2 blockade was achieved using specific inhibitor and genetic knockout mice. Site‐directed mutagenesis, co‐immunoprecipitation, SPR and Bis‐ANS displacement assays were used to identify the potential binding sites of MD2 on CDG.
Results
Our data show that extracellular CDG directly interacts with MD2, leading to activation of the TLR4 signalling pathway and lung injury. Specific inhibitors or genetic knockout of MD2 in mice significantly alleviated CDG‐induced lung injury. Moreover, isoleucine residues at positions 80 and 94, along with phenylalanine at position 121, are essential for the binding of MD2 to CDG.
Conclusion
These results reveal that extracellular CDG induces lung injury through direct interaction with MD2 and activation of the TLR4 signalling pathway, providing valuable insights into bacteria‐induced ALI mechanisms and new therapeutic approaches for the treatment of bacterial co‐infection in COVID‐19 patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang, China.
- Chemical Biology Research Center, School of Pharmaceutical Sciences, Wenzhou Medical University, Wenzhou, Zhejiang, China.
- School of Pharmaceutical Sciences, Hangzhou Medical College, Hangzhou, Zhejiang, China.
ORCID-Profile: Guang Liang, Yi Wang
Förderung
- Key Research Project of Wenzhou City
- National Natural Science Foundation of China
Zitieren
APA
Qian, C., Zhu, W., Wang, J., Wang, Z., Tang, W., Liu, X., Jin, B., Xu, Y., Zhang, Y., Liang, G., & Wang, Y. (2024). Cyclic‐di‐GMP induces inflammation and acute lung injury through direct binding to MD2. Clinical and Translational Medicine. https://doi.org/10.1002/ctm2.1744
Vancouver
Qian C, Zhu W, Wang J, Wang Z, Tang W, Liu X, et al. Cyclic‐di‐GMP induces inflammation and acute lung injury through direct binding to MD2. Clinical and Translational Medicine. 2024. doi:10.1002/ctm2.1744
BibTeX
@article{Qian2024,
author = {Qian, Chenchen and Zhu, Weiwei and Wang, Jiong and Wang, Zhe and Tang, Weiyang and Liu, Xin and Jin, Bo and Xu, Yong and Zhang, Yuyang and Liang, Guang and Wang, Yi},
title = {Cyclic‐di‐GMP induces inflammation and acute lung injury through direct binding to MD2},
journal = {Clinical and Translational Medicine},
year = {2024},
doi = {10.1002/ctm2.1744}
}
EUVIMED